The dynamins represent a superfamily of proteins that have been shown to function
in a wide range of membrane fusion and fission events. An increasing number of
mutations in the human classical dynamins, Dyn-1 and Dyn-2 has been reported,
with diseases caused by these changes ranging from Charcot-Marie-Tooth disorder
to epileptic encephalopathies. The budding yeast, Saccharomyces
cerevisiae expresses a single dynamin-related protein that
functions in membrane trafficking, and is considered to play a similar role to
Dyn-1 and Dyn-2 during scission of endocytic vesicles at the plasma membrane.
Large parts of the dynamin protein are highly conserved across species and this
has enabled us in this study to select a number of disease causing mutations and
to generate equivalent mutations in Vps1. We have then studied these mutants
using both cellular and biochemical assays to ascertain functions of the protein
that have been affected by the changes. Specifically, we demonstrate that the
Vps1-G397R mutation (Dyn-2 G358R) disrupts protein oligomerization, Vps1-A447T
(Dyn-1 A408T) affects the scission stage of endocytosis, while Vps1-R298L (Dyn-1
R256L) affects lipid binding specificity and possibly an early stage in
endocytosis. Overall, we consider that the yeast model will potentially provide
an avenue for rapid analysis of new dynamin mutations in order to understand the
underlying mechanisms that they disrupt